Healthpeak Properties (NYSE:DOC) Now Covered by Analysts at Cantor Fitzgerald

Key Points

• Cantor Fitzgerald has upgraded Healthpeak Properties to a "hold" rating, indicating a shift in sentiment regarding the stock.
• The average target price for Healthpeak Properties is currently at $21.33, with eight analysts giving it a Buy rating.
• Healthpeak Properties reported $0.46 EPS for the last quarter, matching analysts' expectations, but experienced a slight revenue decline compared to the previous year.

Equities research analysts at Cantor Fitzgerald started coverage on shares of Healthpeak Properties (NYSE:DOC - Get Free Report) in a research note issued to investors on Wednesday, MarketBeat reports. The brokerage set a "neutral" rating and a $20.00 price target on the real estate investment trust's stock. Cantor Fitzgerald's target price suggests a potential upside of 4.14% from the stock's previous close.

A number of other research analysts have also recently issued reports on the stock. Raymond James Financial raised shares of Healthpeak Properties from a "market perform" rating to an "outperform" rating and set a $20.00 price objective on the stock in a research note on Monday, September 15th. Scotiabank lowered shares of Healthpeak Properties from a "sector outperform" rating to a "sector perform" rating and cut their target price for the company from $21.00 to $19.00 in a research report on Tuesday, July 29th. Deutsche Bank Aktiengesellschaft reiterated a "hold" rating and set a $18.00 price target (down from $28.00) on shares of Healthpeak Properties in a report on Wednesday, August 20th. Evercore ISI set a $22.00 price target on Healthpeak Properties in a research note on Monday, September 15th. Finally, Morgan Stanley dropped their price target on Healthpeak Properties from $22.00 to $21.00 and set an "overweight" rating for the company in a research note on Friday, August 22nd. Eight analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $21.33.

Healthpeak Properties Stock Performance

Shares of NYSE:DOC opened at $19.21 on Wednesday. The company's 50 day simple moving average is $17.82 and its 200 day simple moving average is $18.05. The stock has a market capitalization of $13.35 billion, a price-to-earnings ratio of 80.02, a price-to-earnings-growth ratio of 2.47 and a beta of 1.09. The company has a debt-to-equity ratio of 1.06, a current ratio of 1.28 and a quick ratio of 1.28. Healthpeak Properties has a 1 year low of $16.63 and a 1 year high of $23.26.

Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its quarterly earnings data on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.46. The business had revenue of $694.35 million for the quarter, compared to analysts' expectations of $697.14 million. Healthpeak Properties had a net margin of 5.90% and a return on equity of 1.85%. The firm's quarterly revenue was down .2% compared to the same quarter last year. During the same period last year, the firm posted $0.45 earnings per share. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. As a group, research analysts predict that Healthpeak Properties will post 1.86 EPS for the current fiscal year.

Insider Activity at Healthpeak Properties

In other Healthpeak Properties news, CEO Scott M. Brinker purchased 2,930 shares of the business's stock in a transaction dated Thursday, July 31st. The shares were bought at an average price of $17.06 per share, for a total transaction of $49,985.80. Following the completion of the acquisition, the chief executive officer owned 210,416 shares in the company, valued at approximately $3,589,696.96. This trade represents a 1.41% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders have acquired a total of 8,783 shares of company stock worth $150,129 in the last quarter. 0.23% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Healthpeak Properties

A number of hedge funds have recently modified their holdings of DOC. TCTC Holdings LLC lifted its holdings in shares of Healthpeak Properties by 124.3% during the first quarter. TCTC Holdings LLC now owns 1,355 shares of the real estate investment trust's stock worth $27,000 after purchasing an additional 751 shares during the period. Brooklyn Investment Group lifted its holdings in shares of Healthpeak Properties by 198.9% during the first quarter. Brooklyn Investment Group now owns 1,312 shares of the real estate investment trust's stock worth $27,000 after purchasing an additional 873 shares during the period. Rexford Capital Inc. acquired a new position in Healthpeak Properties in the second quarter valued at $28,000. S.A. Mason LLC lifted its holdings in Healthpeak Properties by 160.9% in the first quarter. S.A. Mason LLC now owns 1,500 shares of the real estate investment trust's stock valued at $30,000 after buying an additional 925 shares during the period. Finally, Dagco Inc. acquired a new position in Healthpeak Properties in the first quarter valued at $30,000. Institutional investors and hedge funds own 93.57% of the company's stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.